Electronic Bunsen UK AND EU Plug |
|||
| BA6101 | Scientific Laboratory Supplies | EACH | EUR 706.8 |
Igg Antibody Laboratories manufactures the igg antibody test produced by abbott uk reagents distributed by Genprice. The Igg Antibody Test Produced By Abbott Uk reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Igg products are available in stock. Specificity: Igg Category: Antibody Group: Test Produced
UK-5099 |
||
| Biovision | each | EUR 652.8 |
UK-5099 |
||
| Biovision | each | EUR 210 |
UK 14,304 |
||
| ApexBio | 10 mg | EUR 228 |
UK 14,304 |
||
| ApexBio | 100 mg | EUR 1232.4 |
UK 14,304 |
||
| ApexBio | 5 mg | EUR 166.8 |
UK 14,304 |
||
| ApexBio | 50 mg | EUR 714 |
UK 1 |
||
| ApexBio | 1 mg | EUR 435.6 |
|
Description: UK 1, an unusual bis-benzoxazole metabolite isolated from Streptomyces sp. 517-02, is an inhibitor of topoisomerase II (Topo II) and hepatitis C viral replication. |
||
anti-HIV-1 p24 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
| 012-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HIV-1 p24 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
anti-HIV-1 p17 IgG1 (monoclonal) Produced against a recombinant protein |
|||
| 014-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HIV-1 p17 IgG1 (monoclonal) Produced against a recombinant protein |
|||
anti-HIV-1 gp41 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
| 015-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HIV-1 gp41 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
anti-HSV (II) gB IgG1 (monoclonal) Produced against a HSV (II) infected cells. |
|||
| 021-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HSV (II) gB IgG1 (monoclonal) Produced against a HSV (II) infected cells. |
|||
anti-HCMV IE pp72 IgG2a (monoclonal) Produced against a HCMV IE concentrate. |
|||
| 022-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HCMV IE pp72 IgG2a (monoclonal) Produced against a HCMV IE concentrate. |
|||
anti-HCMV IE pp65 IgG1 (monoclonal) Produced against a HCMV infected cells. |
|||
| 023-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HCMV IE pp65 IgG1 (monoclonal) Produced against a HCMV infected cells. |
|||
anti-HIV-1 p55/17 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
| 013-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HIV-1 p55/17 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
anti-HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate |
|||
| 020-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate |
|||
anti-Dengue NS1 Type 2 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
| 111-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-Dengue NS1 Type 2 IgG1 (monoclonal) Produced against a recombinant protein. |
|||
anti-SLAM anti-CDw150 IgG2a (monoclonal) Produced against an activated B cell line. |
|||
| 059-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-SLAM anti-CDw150 IgG2a (monoclonal) Produced against an activated B cell line. |
|||
anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. |
|||
| 027-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. |
|||
anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. |
|||
| 276-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. |
|||
anti-HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. |
|||
| 0116-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. |
|||
anti-HCV core IgG2a (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. |
|||
| 0117-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HCV core IgG2a (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. |
|||
anti-GSK3 Beta IgG2a (monoclonal). Produced against a recombinant Xenopus laevis protein. |
|||
| 011-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-GSK3 Beta IgG2a (monoclonal). Produced against a recombinant Xenopus laevis protein. |
|||
anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 |
|||
| 245-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 |
|||
anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 |
|||
| 247-A-100ugvial | Virogen | 100 ug/vial | EUR 150 |
|
Description: anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 |
|||